SPARC Q1 net loss widens to Rs 78.84 crore
SPARC was formed in 2007, when Sun Pharmaceutical Industries separated out its active projects in drug discovery and innovation into a new company.
By PTI | Updated:
NEW DELHI: Sun Pharma's research and drug discovery arm Sun Pharma Advanced Research Company ( SPARC) today reported widening of net loss to Rs 78.84 crore for the first quarter ended June 30.
The company had posted a net loss of Rs 36.14 crore for the June quarter of 2016-17 fiscal, SPARC said in a filing to BSE.
Total income of the company however rose to Rs 24.62 crore as against Rs 24.50 crore for the same period a year ago.
SPARC was formed in 2007, when Sun Pharmaceutical Industries separated out its active projects in drug discovery and innovation into a new company.
The company had posted a net loss of Rs 36.14 crore for the June quarter of 2016-17 fiscal, SPARC said in a filing to BSE.
Total income of the company however rose to Rs 24.62 crore as against Rs 24.50 crore for the same period a year ago.
SPARC was formed in 2007, when Sun Pharmaceutical Industries separated out its active projects in drug discovery and innovation into a new company.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
Related Articles
SPARC Q1 loss widens to Rs 36.41 croreADVERTISEMENT
